Clinical Trials Directory

Trials / Completed

CompletedNCT04908943

RENEW Scleroderma: A Peer-Mentored, Web Intervention for Resilience-based, Energy Management to Enhance Wellbeing and Fatigue

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
174 (actual)
Sponsor
University of Michigan · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The researchers seek to understand if the Resilience-based, Energy Management to Enhance Wellbeing and Fatigue (RENEW) program helps with scleroderma symptom management and disease burden. The researchers think that those participants who receive the intervention will have clinically meaningful changes of symptom management and disease burden.

Conditions

Interventions

TypeNameDescription
BEHAVIORALRENEWRENEW is a 12-week, peer-led, web-based program to help people with scleroderma learn skills that can be used to manage disease symptoms and improve well-being.

Timeline

Start date
2021-08-28
Primary completion
2023-05-29
Completion
2023-05-29
First posted
2021-06-01
Last updated
2023-11-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04908943. Inclusion in this directory is not an endorsement.

RENEW Scleroderma: A Peer-Mentored, Web Intervention for Resilience-based, Energy Management to Enhance Wellbeing and Fa (NCT04908943) · Clinical Trials Directory